CD274 and neoplasm: The platform using the SP142 clone is scored by ICa (percentage of tumor area covered by PD-L1 positive immune cells)47, and the platform using the 22C3 clone, by CPS (positive tumor or immune cells as percentage of all tumor cells), without possibility of interchange between both scoring systems48.